Andromeda Biotech Ltd. Report issue

For profit Phase 3
Founded: Yavne Israel (2007)
Status: Acquired by Hyperion Therapeutics (2014) → now Horizon Pharma (2015)

Organization Overview

First Clinical Trial
2007
NCT00615264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree